New research published in the Journal of Physiology presents a breakthrough in the treatment of Restless Legs Syndrome (RLS).
RLS is a common condition of the nervous system that causes an overwhelming irresistible urge to move the legs. Patients complain of unpleasant symptoms such as tingling, burning and painful cramping sensations in the leg. More than 80% of people with RLS experience their legs jerking or twitching uncontrollably, usually at night.
Until now it was thought that RLS is caused by genetic, metabolic and central nervous system mechanisms. For the first time the researchers show that, in fact, it is not only the central nervous system but also the nerve cells targeting the muscles themselves that are responsible.
This new research indicates that the involuntary leg movements in RLS are caused by increased excitability of the nerve cells that supply the muscles in the leg, which results in an increased number of signals being sent between nerve cells.
Targeting the way messages are sent between nerve cells to reduce the number of messages to normal levels may help prevent the symptoms of RLS occurring. This could be achieved by new drugs that block the ion channels that are essential for the communication between nerve cells.
The research conducted by the University of Gottingen in conjunction with the University of Sydney and Vanderbilt University involved measuring the nerve excitability of motor nerve cells of patients suffering with RLS and healthy subjects.
The next step is to investigate the effect of different medications in patients and the effect on RLS.
Dirk Czesnik, corresponding author of the study, commented on the findings:
‘Patients who suffer from Restless legs syndrome complain of painful symptoms in the legs leading to sleep disturbances. The mechanisms for RLS are still not completely understood. We have shown that also the nerve cells supplying muscles in the leg are responsible and hereby additional drug treatments may be ahead targeting these nerve cells.’
The Latest on: Restless legs syndrome
via Google News
The Latest on: Restless legs syndrome
- Restless legs syndrome is a sleep-wrecking nightmareon July 1, 2021 at 9:10 pm
Restless legs syndrome is thought to be more common than type 2 diabetes, yet its causes are unknown and research limited, with doctors often giving treatments that either don't work or make it ...
- Restless Legs Syndromeon July 1, 2021 at 5:01 pm
An algorithm published by the Medical Advisory Board of the Restless Legs Syndrome Foundation advises clinicians to take different treatment approaches for intermittent and daily RLS.  Some of ...
- Restless Legs Syndrome in Childrenon July 1, 2021 at 5:01 pm
Rajaram and colleagues define growing pains as "Ill-defined limb discomforts in children that do not meet criteria for other diagnoses, such as arthritis, other bone and joint pathology ...
- Restless legs syndrome is a sleep-wrecking nightmareon June 30, 2021 at 5:10 pm
Restless legs syndrome - the irresistable, relentless urge to move your legs - is thought to affect more people than type 2 diabetes, yet little is known about the condition EVERY night for the ...
- Restless Leg Syndrome Newson June 30, 2021 at 5:00 pm
June 7, 2019 — Small intestine bacterial overgrowth (SIBO) may be more prevalent among patients with restless legs syndrome (RLS), according to preliminary findings from a small, new ...
- Solving the mystery of restless legs syndrome: Acid-blocking medicines may play roleon June 29, 2021 at 8:00 am
It’s restless legs syndrome (RLS), a neurological and sleep disorder that causes discomfort and sometimes pain in the legs, particularly at night. It triggers a constant urge to move the legs that ...
- Restless Legs Syndrome Linked to Obesity, Fat Waistlineson June 27, 2021 at 5:00 pm
April 7, 2009— -- A new study suggests that people who have big bellies are more likely to develop restless legs syndrome (RLS), a condition that makes sleep or rest nearly impossible.
- Restless legs syndrome: What causes RLS?on June 24, 2021 at 2:35 pm
Restless legs syndrome, which you might have heard referred to as Willis-Ekbom disease, is a condition of the nervous system. RLS causes an overwhelming irresistible urge to move the legs.
- Gabapentin Market Share will reach USD 1686.7 million by the end of 2026, growing at a CAGR of 1.8% , Segmented by Top companies Dataon June 24, 2021 at 8:02 am
Global Gabapentin Market The global Gabapentin market is valued at USD 1486.6 million in 2019. The market size will reach USD 1686.7 million by the end of 2026, growing at a CAGR of 1.8% during ...
via Bing News